Cabaletta Bio, Inc.
CABA
$1.56
-$0.03-1.89%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -144.29M | -126.76M | -115.86M | -104.16M | -89.98M |
| Total Depreciation and Amortization | 1.85M | 1.80M | 1.71M | 1.58M | 1.51M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 30.98M | 27.23M | 24.32M | 21.65M | 17.60M |
| Change in Net Operating Assets | 6.79M | 2.69M | 1.61M | -609.00K | -2.96M |
| Cash from Operations | -104.67M | -95.04M | -88.22M | -81.55M | -73.83M |
| Capital Expenditure | -1.58M | -2.18M | -2.21M | -2.02M | -1.83M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -24.04M | 49.50M | 49.50M | 38.32M | 25.82M |
| Cash from Investing | -25.61M | 47.32M | 47.29M | 36.30M | 23.99M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -4.45M | -1.45M | -897.00K | -- | -- |
| Issuance of Common Stock | 101.72M | 5.72M | 12.57M | 100.35M | 100.38M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 97.26M | 4.27M | 11.68M | 100.35M | 100.38M |
| Foreign Exchange rate Adjustments | 18.00K | -13.00K | -20.00K | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -33.00M | -43.46M | -29.28M | 55.11M | 50.54M |